Directive 75/318/EEC
title: "Directive 75/318/EEC" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["pharmaceuticals-policy", "european-union-directives", "european-union-directives-by-number", "1975-in-law", "1975-in-the-european-economic-community"] topic_path: "law" source: "https://en.wikipedia.org/wiki/Directive_75/318/EEC" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. This directive of the European Union sought to bring the benefits of innovative pharmaceuticals to patients across Europe by introducing the mutual recognition, by Member States, of their respective national marketing authorisations.
The Directive says that Member States shall take all appropriate measures to ensure that the applications for marketing authorization, are submitted by the applicants in accordance with the guidelines of the Directive.
References
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::